A multilevel screening pipeline in zebrafish identifies therapeutic drugs for GAN
Abstract Giant axonal neuropathy (GAN) is a fatal neurodegenerative disorder for which there is currently no treatment. Affecting the nervous system, GAN starts in infancy with motor deficits that rapidly evolve toward total loss of ambulation. Using the gan zebrafish model that reproduces the loss...
Saved in:
| Main Authors: | Léa Lescouzères, Cédric Hassen‐Khodja, Anaïs Baudot, Benoît Bordignon, Pascale Bomont |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2023-05-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202216267 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Three siblings with giant axonal neuropathy caused by a novel variant in GAN gene: the first report from Egypt
by: Abdelrahim A. Sadek, et al.
Published: (2025-07-01) -
Giant axonal neuropathy: A differential diagnosis of consideration
by: Pınar Edem, et al.
Published: (2019-04-01) -
Myasthenia gravis in clinical practice
by: Eduardo de Paula Estephan, et al.
Published: (2022-08-01) -
Sporadic ALS hiPSC-derived motor neurons show axonal defects linked to altered axon guidance pathways
by: Lisha Ye, et al.
Published: (2025-03-01) -
Modeling of Charcot-Marie-Tooth disease in zebrafish
by: Małgorzata Korzeniowska née Wiweger, et al.
Published: (2025-08-01)